MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/105/0.1/21.03.25 Stock

Warrant

DE000MG4D2P3

Market Closed - Börse Stuttgart 14:56:51 2024-07-08 EDT
0.24 EUR -14.29% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/105/0.1/21.03.25
Current month-14.29%
1 month-65.22%
Date Price Change
24-07-08 0.24 -14.29%
24-07-05 0.28 0.00%
24-07-03 0.28 +3.70%
24-07-02 0.27 -10.00%
24-07-01 0.3 +7.14%

Delayed Quote Börse Stuttgart

Last update July 08, 2024 at 02:56 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D2P
ISINDE000MG4D2P3
Date issued 2024-05-16
Strike 105 $
Maturity 2025-03-21 (256 Days)
Parity 10 : 1
Emission price 1.78
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.76
Lowest since issue 0.24
Delta0.21x
Omega 4.110
Premium92.28x
Gearing19.56x
Moneyness 0.5343
Difference Strike 48.94 $
Difference Strike %+46.61%
Spread 0.03
Spread %10.71%
Theoretical value 0.2650
Implied Volatility 65.13 %
Total Loss Probability 91.17 %
Intrinsic value 0.000000
Present value 0.2650
Break even 107.87 €
Theta-0.01x
Vega0.01x
Rho0.01x

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
56.06 USD
Average target price
83.43 USD
Spread / Average Target
+48.82%
Consensus